The microbiome in HLA-B27-associated disease: implications for acute anterior uveitis and recommendations for future studies.


Journal

Trends in microbiology
ISSN: 1878-4380
Titre abrégé: Trends Microbiol
Pays: England
ID NLM: 9310916

Informations de publication

Date de publication:
02 2023
Historique:
received: 19 05 2022
revised: 09 08 2022
accepted: 09 08 2022
pubmed: 5 9 2022
medline: 27 1 2023
entrez: 4 9 2022
Statut: ppublish

Résumé

The pathogenesis of human leukocyte antigen (HLA)-B27-associated diseases such as acute anterior uveitis (AAU) and ankylosing spondylitis (AS) remains poorly understood, though Gram-negative bacteria and subclinical bowel inflammation are strongly implicated. Accumulating evidence from animal models and clinical studies supports several hypotheses, including HLA-B27-dependent dysbiosis, altered intestinal permeability, and molecular mimicry. However, the existing literature is hampered by inadequate studies designed to establish causation or uncover the role of viruses and fungi. Moreover, the unique disease model afforded by AAU to study the gut microbiota has been neglected. This review critically evaluates the current literature and prevailing hypotheses on the link between the gut microbiota and HLA-B27-associated disease. We propose a new potential role for HLA-B27-driven altered antibody responses to gut microbiota in disease pathogenesis and outline recommendations for future well-controlled human studies, focusing on AAU.

Identifiants

pubmed: 36058784
pii: S0966-842X(22)00220-7
doi: 10.1016/j.tim.2022.08.008
pii:
doi:

Substances chimiques

HLA-B27 Antigen 0

Banques de données

ClinicalTrials.gov
['NCT01330901', 'NCT03726645', 'NCT03058900']

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-158

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests No interests are declared.

Auteurs

Rohit Parthasarathy (R)

School of Medical Sciences, Faculty of Medicine & Health, UNSW, Sydney, Australia.

Fernando Santiago (F)

School of Medical Sciences, Faculty of Medicine & Health, UNSW, Sydney, Australia.

Peter McCluskey (P)

Save Sight Institute, Sydney Eye Hospital, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Nadeem O Kaakoush (NO)

School of Medical Sciences, Faculty of Medicine & Health, UNSW, Sydney, Australia.

Nicodemus Tedla (N)

School of Medical Sciences, Faculty of Medicine & Health, UNSW, Sydney, Australia.

Denis Wakefield (D)

School of Medical Sciences, Faculty of Medicine & Health, UNSW, Sydney, Australia; Center for Immunology and Immunopathology, South Eastern Area Health Service, Sydney, Australia. Electronic address: d.wakefield@unsw.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH